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In the previous paper we demonstrated for peripheral blood leukocytes (PBL) 1 
from  nonimmune  primate  donors  the  dependence  of dengue  2  virus  (D2V) 
permissiveness upon the presence of non-neutralizing anti-dengue IgG in cul- 
ture medium (1). Infection occurs in the absence of complement and is dependent 
upon a protease-resistant leukocyte Fc receptor.  When the infectious dose is at 
or  above  a  multiplicity  of infection  (MOI)  of 0.001  and  mononuclear  PBL 
separated from anti-coagulated blood are standardized to 1 ×  10e/ml,  antibody- 
dependent D2V infection is highly reproducible.  The significance of antibody- 
enhanced  infection  as  a  possible  mechanism  in  the  pathogenesis  of severe 
dengue infections in infants born in dengue endemic areas was discussed. In this 
paper we report studies on the identification and the enumeration of human and 
simian blood and simian tissue leukocytes supporting antibody-enhanced den- 
gue infection, in vitro. 
Materials and Methods 
Preparation of virus, antibody, separation of leukocytes, and methods of leukocyte propagation 
are as previously described (1). Unless otherwise specified, PBL were infected with D2V at a MOI 
between 0.1 and 0.01 in a final concentration of 1:200 of H-187 anti-dengue 4 (aD4) and were grown 
in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), gluta- 
mine, and antibiotics (complete RPMI). 
Leukocyte  Counts  and Identification.  Leukocyte suspensions  diluted  in trypan  blue  and in 
leukocyte diluent were counted in a hemacytometer. Viable cells were those which excluded 0.2% 
trypan blue after 5 rain incubation at 37°C. Methods for counting monocytes and sheep erythrocyte 
(SRBC)-rosetted (T) and membrane immunoglobulin-bearing (B) lymphocytes are described sepa- 
rately. 2 Briefly,  1  x  105 PBL in 0.1  ml medium were incubated  with an equal volume of 0.5% 
neuraminidase-treated SRBC at 37°C for 5 min, then centrifuged at 100 g for 5 rain, and incubated 
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pokeweed mitogen; T lymphocyte, SRBC-rosetted lymphocyte. 
20'Rourke,  E.  J.,  S.  B.  Halstead,  A.  C.  Allison,  and  T.  A.  E.  Platts-Mills.  1977. Specific 
lethality of silica for human mononuclear phagocytes, in vitro. J. Immunol. Methods.  In press. 
218  THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  • VOLUME  146, 1977 S.  B.  HALSTEAD,  E.  J.  O'ROURKE,  AND  A.  C.  ALLISON  219 
further  18 h  at 4°C.  Cells were resuspended  by gentle rocking and counted after adding a  final 
concentration  of 0.0002%  acridine  orange  (Euchrysine  3R;  G.  T.  Gurr,  London,  England)  to 
facilitate identification of nonrosetted lymphocytes when viewed simultaneously under transmit- 
ted white and incident blue light. Only cells with three or more rosetted SRBC were counted. For 
B-cell counts,  10 ~1 of undiluted fluorescein isothiocyanate  (FITC)-conjugated goat anti-human 
immunoglobulin  (Nordic Diagnostics,  Sera  Service Limited,  Maidenhead,  Berkshire,  England) 
was added to 0.1 ml L-15 medium containing 2 x  105 washed PBL. After 60 rain incubation at 4°C, 
cells were washed three times in cold L-15 medium and counted under phase and UV microscopy. 
Cells having monocyte morphology (see below) with surface immunoglobulin (Ig) were not counted 
as B  lymphocytes.  Counts were expressed as percent of total mononuclear cells. For monocyte 
counts,  PBL  were  incubated  with  polystyrene  beads  (Bacto-Latex,  0.81;  Difco  Laboratories, 
Detroit, Mich.) at a bead to cell ratio of 500:1 for 90 rain at 37°C. The cells were then treated with 
0.0002%  acridine orange for 5-10 rain. Under blue light illumination this stained DNA a brilliant 
green and lysosomal enzymes yellow to orange (2). Monocytes were visualized under both phase 
microscopy and UV illumination.  Monocytes are defined as cells with a  ruffled cell membrane 
containing  ingested  polystyrene  particles.  In  acridine  orange-treated  preparations,  a  bright 
orange lysosomal fluorescence seen in  over 95%  of cultured monocytes facilitated recognition. 
Monocytes were considered viable if they exhibited nuclear acridine orange fluorescence. Differen- 
tial counts  were done on at least 500  cells per slide.  Cells exhibiting antibody-dependent  cell- 
mediated cytotoxicity (K cells) were assayed by a  microtechnique based on the method of Mac- 
Lennon et al.  (3), using human PBL as effectors and 51Cr-labeled Chang cells incubated with or 
without rat anti-Chang serum as targets. 
Preparation of Leukocyte Suspensions from Lymphoid Organs.  Lymphatic organs  were ob- 
tained from adult rhesus monkeys by surgery or immediately after pentothal euthanasia.  Bone 
marrow was removed from the femur and suspended in phosphate-buffered saline (PBS). Lymph 
node, spleen, and thymus were minced with scissors and expressed through a stainless steel wire 
mesh (gauge 200) using a disposable 10-ml plastic syringe plunger. Cell suspensions were washed 
three times in PBS, counted, and suspended at 1 x  105 mononuclear cells/m] in RPMI-1640 with 
10% FBS. Daily counts of viable mononuclear cells and phagocytic cells were done. 
Infectious Center Assay.  D2V  was  incubated  with  PBL  in  an  appropriate  dilution  of test 
antibody  or  control  for  90  min  at  37°C.  Cells were  then  washed  in  50  volumes  of PBS  and 
resuspended to 1 ml in 1:10 monkey anti-dengue 2 for 30 min at 37°C. Anti-dengue 2 was removed 
by washing three times in PBS. Viable cells were counted and the concentration adjusted to i  x  105 
ml. Between 5 x  105 and 1 x  10  s PBL were applied to LLC-MK2 monolayers or added to 0.4 ml PS 
cell suspensions  (1).  With the addition of 105 or more PBL,  toxic changes in kidney cells were 
observed.  Immediately after  inoculating  PBL  on  LLC-MK2  monolayers  an  agar  overlay was 
added; with PS cells, L-15-carboxymethyl cellulose was added after 4 h  incubation. 
Fluorescence Microscopy.  Dengue  antigen(s)  in  infected PBL was localized by fluorescence 
microscopy using the direct  staining  technique.  Convalescent human  serum from a  secondary 
dengue  infection  was  supplied  by  Dr.  Duane  Gubler,  Department  of Tropical  Medicine  and 
Medical  Microbiology,  University of Hawaii,  Honolulu.  This  serum  had  a  hemagglutination- 
inhibition  titor vs.  dengue  1-4  antigens  of 1:20,480  and  a  dengue  2  serum  had  a  50%  plaque 
reduction  neutralization  titer  of 1:10,000.  Globulins  from  this  serum  were  precipitated  with 
saturated ammonium sulfate, dialyzed, and adjusted to 25 mg/ml. To 1.8 ml of Ig solution, 0.2 ml of 
a carbonate-bicarbonate buffer, 0.5 M, pH 9.0,  was added. The pH was corrected to 9.0 and FITC 
(Nordic Diagnostics, Sera Service Limited), 20  /zg/ml protein,  was added.  The preparation  was 
incubated and stirred for 18 h at 4°C and then exhaustively dialyzed with PBS, pH 7.2,  to remove 
unconjugated FITC.  Conjugated Ig was deaggregatod by ultracentrifugation at  100,000 g  for 60 
min. PBL suspensions were counted and 0.2 ml containing 20,000 cells were sedimented (Cytospin; 
Shandon Southern Instruments, Camberly, Surrey, England) on alcehol-cleaned or gelatin-coated 
glass slides, air-dried, fixed in acetone at -20°C for 10 min, and then stored at -70°C until stained. 
Approximately 0.05 ml of a 1:10 dilution of FITC-conjugated anti-dengue was incubated on PBL for 
30 rain at 37°C. Cells were then washed three times in PBS, pH 7.4,  rinsed with distilled water, 
and counter-stained with 0.005%  Evan's Blue for 10 vain at room temperature.  Slides were again 
rinsed  with  distilled water,  air dried,  and  a  cover slip  mounted  in  50%  glycerol,  pH  9.0.  To 
visualize FITC, a  Zeiss microscope, model WL equipped for photomicrography  (Carl Zeiss, Inc., 
New York), with transmitted light phase-contrast microscopy and incident blue light from a  UV 220  DENGUE  AND  MONOCYTES.  II 
light source passing through KP 490, KP 500,  Rfl 510, and LF 528 filters was used.  Noninfected 
PBL  were  stained  with  anti-dengue  FITC,  infected  PBL  were  stained  with  FITC-conjugated 
antibodies to  nondengue antigens,  and  blocking experiments  with  human  and  monkey  anti- 
dengue 2 were performed to test the specificity of FITC localization to dengue 2 antigen. 
Silica  Treatment  of Leukocytes.  Silica  particles,  <5  ~m  in  diameter  (Quartz  DQ  No.  12, 
DSrentrop, from Dr. A. C. Allison) were suspended at 1 mg/ml in RPMI-1640 with 10% fetal bovine 
serum. The suspension was sonicated for 2 rain, then kept at 4°C for 18 h, and resonicated just 
before adding to leukocyte suspensions. Silica suspensions were always freshly prepared as their 
effectiveness in killing macrophages in vitro declined rapidly on storage either in liquid or frozen 
state. 
Radiation.  Separated and washed human PBL were cultured in RPMI-1640 with 10% FBS for 
24 h  then exposed for varying times to a  cobalt-60 source emitting 1.65 rads/s.  PBL were either 
infected immediately after radiation or 24 h  later. 
Separation of Leukocytes  on Nylon Wool Columns or Glass or Plastic Surfaces.  Loose, sterile 
nylon wool was prepared and packed in 10-ml plastic disposable syringes as described by Dickler 
(4).  Up to 5  x  107 cells were suspended in 5 ml of 10%  FBS in RPMI-1640 or in 5  ml of 100% 
autologous serum and loaded onto nylon columns. After incubation at 37°C  for 60 and 30 min, 
respectively,  cells were eluted  from columns with 20 cm  3 of cold PBS.  Cells were counted and 
identified as described above.  Monolayers of leukocytes adherent to 50-ram plastic Petri dishes 
(Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) were obtained with cells suspended in 10% FBS 
in RPMI-1640 according to the method described by Koller et al.  (5). 
Results 
Peripheral  Blood.  Identification  of  leukocytes  supporting  antibody-en- 
hanced  D2V replication  was approached by attempting  to isolate,  remove, or 
destroy specific leukocyte types. 
Adherence.  A large number of studies was done to characterize the glass- or 
plastic-adherence properties of dengue-permissive cells. A typical experimental 
result is diagrammed  in Fig.  1.  After  1 h  incubation of 2  x  10  e mononuclear 
leukocytes in 2 ml complete RPMI, nonadherent cells were removed by vigorous 
pipetting of plastic surface with large volumes of PBS. Cells adherent to each 50- 
mm  Falcon plastic  Petri  dish were counted using an  inverted  microscope.  In 
companion Petri dishes,  adherent  cell populations were differentially counted 
after incubation with latex beads using phase microscopy and observing acri- 
dine orange stain under fluorescence microscopy. Infected cells as measured by 
the  infectious  center  method  were  most  numerous  in  the  strongly  adherent 
population,  but were also found among cells washed from the plastic surface. 
Monocytes were found in both populations. 
Further attempts were made to remove adherent cells on nylon wool columns 
treated with 10% fetal bovine serum or 100% autologous serum.  In the former 
method, both monocytes and B lymphocytes were depleted (Fig. 2). In the latter, 
monocytes were selectively depleted while  B  lymphocytes and  K  cells passed 
through  the  column  (Fig.  3).  D2V-permissive cells were always absent when 
99% monocytes were removed from suspension.  No plaques were seen in three 
replicate  wells  inoculated  with  5  ×  105  cells.  The  number  of infected  cells 
measured by the infectious center method in unfractionated  PBL was always 
very small.  Results shown are representative  of three  experiments  with each 
type of column. 
Radiation.  Portion of PBL suspensions from two nonimmune human donors 
were exposed to 300, 600 and 1,200 rads. These cells and nonirradiated  controls 
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Fro. i.  Infectious  center assay of  D2V-infected  human PBL among plastic-adherent  and 
nonadherent cells.  See text  for  leukocyte identification  techniques and  experimental meth- 
ods. Mononuclear leukocytes separated on Ficoll-Hypaque  (FH) and assayed on PS cells. 
Infectious  centers (cells)  expressed as a fraction  of  total  assayed. 
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Fro, 2.  Infectious  center assay of  D2V-infected human PBL after  application  to  a 10% fetal 
bovine serum nylon wool column. 
bated at  37°C and assayed for  virus content. No difference was observed in  virus 
replicated in irradiated cells  or controls. 
Selective  Killing of Mononuclear  Phagocytes.  We have shown  that  silica 
destroys human mononuclear phagocytes but has no effect on B- or T-lympho- 222  DENGUE  AND  MONOCYTES.  II 
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FIG.  3.  Infectious center assay of D2V-infected human PBL after application to a  100% 
autologous serum nylon wool column. 
cyte  numbers  or  on  B-  or  T-lymphocyte  or  K-cell  function. 2 Many  of these 
published  observations  accompanied  studies  reported here.  Freshly  prepared 
silica suspensions were added to PBL before or after inoculation of D2V plus aD4 
at concentrations ranging between 0.1 and 100 ftg/ml. Monocyte counts and D2V 
titers in silica-treated human  PBL and controls are given for a  range of silica 
concentrations in Table I. The lethal effects of silica on human monocytes and 
reduction in D2V replication compared with controls were approximately paral- 
lel.  A  summary of representative  experiments  using  rhesus  PBL is given in 
Table II. 
Fluorescent  Antibody  (FA)  Identification  of  Dengue  Antigen  in 
PBL.  Human PBL infected with D2V were removed at 12-h intervals during 
96 h of culture. Cells were counted then incubated with latex beads for 90 min at 
37°C.  Air-dried PBL were stained with human anti-dengue FITC. Noninfected 
PBL were stained in similar fashion.  In addition,  infected PBL were stained 
with  a  FITC-conjugated  antiserum  to  an  irrelevant  antigen.  Distinct  focal 
perinuclear fluorescence seen only in D2V-infected cells stained with FITC anti- 
dengue  was first  observed at  24 h.  Focal areas  of fluorescence gradually  en- 
larged to maximum size at 60 h.  Only rarely was the entire cytoplasm stained 
with  FITC.  From  60 h  on,  degenerative  changes  and  degenerated  cells were 
noted and the number of infected cells decreased. 
Correlations between fluorescence-positive cells, infectious center assay, and 
virus titers  are shown in Table HI.  Infectious center enumeration  performed 
after 90 min incubation of virus antibody with PBL showed poor correlation with 
virus content  of PBL suspension  24-96  h  later.  However, the  correlation  be- 
tween the concentration of FA-positive cells and viral titer was good. In these 
experiments, fluorescent-positive cells comprised less than 1% of blood mononu- 
clear phagocytes. In observations not shown, FA-positive cells achieved but did S.  B.  HALSTEAD,  E.  J.  O'ROURKE,  AND  A.  C.  ALLISON  223 
TABLE  I 





Mean  ±  SD, mononuclear phagocytes x  i0  5  Mean PFU  ×  1,000/ml 
Day of culture  Day of culture 
0  1  2  -3  2  3 
t~g  /rn  l 
None  14  8.9  -- 0.8  9.3  --  1.1  10.8  ±  0.9  10.6  ±  0.8  3.1  ±  0.8  1.7  ±  0.4 
0.1  4  8.1  -  1.7  12.1  ±  2.2  14.6  ±  3.2  3.7  --  0.4  2.8  ±  0.4 
1.0  4  8.0  ±  1.4  10.8  _  2.3  10.2  ±  2.1  3.5  ±  0.5  2.0  --  0.8 
10.0  4  3.7  --  1,3  4.1  _+  1.2  3.3  ±  1.5  1.7  -+ 0.2  0.5  ±  0.1 
25.0  1  7.4  5.2  5.3  0.03  -- 0.0  0.2  ±  0.1 
50.0  1  0.7  2.2  3.8  0.04  ±  0.0  0.04  ...  0.0 
100.0  10  2.9  ±  0.8  1.3  ±  0.4  1.0  ±  0.5  0.07  ±  0.0  0.04  _+  0.0 
TABLE  II 
Effect of lO0 p~/ml Particulate Silica on Rhesus Monkey Mononuclear Phagocytes and 
D2V Replication in PBL Cultures 
Monkey  Silica 
Mononuclear phagocytes ×  105  PFU  x  1,000/ml 
Day of culture  Day of culture 
0  1  2  3  6  2  3  4  5 
Rh 113  None  3.2  4.8  6.2  10.6  20.8  2.2  3.5  3.5  3.5 
100  ~g/ml  1.0  0.4  0.2  0.8  0.15  0.03  0.05  0.05 
Rh 114  None  6.8  8.0  10.8  9.2  20.4  3.8  3.5  5.0  5.0 
100  ~g/ml  3.4  1.2  1.2  0.2  0.03  0.03  0.1  0.1 
not exceed 1% of the monocyte population. In seven human leukocyte prepara- 
tions examined, 73% of fluorescence-positive cells contained ingested latex. All 
dengue fluorescence-positive cells were large, had ample cytoplasm, and had 
ruffled cytoplasmic margins. 
Infectious Center Assay.  Numerous attempts were made to count dengue- 
infected cells by infectious center techniques. The method most commonly used 
involved infecting PBL with D2V, washing to remove unabsorbed virus, incu- 
bating with anti-dengue 2 to neutralize virus not internalized, again washing, 
counting, and inoculating onto LLC-MK2 monolayers or in PS cell suspensions. 
In 25 attempts, the largest number of D2V-infected cells enumerated 90 min 
after incubation with immune complex was 100 per 10  e mononuclear PBL and 
the mean was 31/106. A larger number of infected PBL was measured when cells 
were allowed to adhere to a plastic surface before washing and neutralizing the 
virus. The number of infected PBL enumerated aider 1 or more days incubation 
was irregularly higher than the number measured shortly after initial infection. 
PBL incubated for 48 h or longer are productively infected and release dengue 
virus into culture medium. It is theoretically impossible to quantitate infected 
cells by the infectious center assay at this time. 
Tissue Leukocytes.  Leukocyte suspensions were prepared from lymphatic 
tissues freshly obtained from five nonimmune rhesus monkeys. After standard- 
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TABLE  III 
Enumeration of Infected Human PBL by Fluorescent Antibody and 
Infectious  Center Techniques  Compared with Plaque Assays of 
Sampled Cultures 
Mean D2V-positive 
cells/108  PBL 
Exp.  Hour of  % Mono-  PFU  × 1,000/ 
study  cytes  Infectious  10  o  PBL 
FA 
center* 
1  0  8.1  26  ND5  ND 
1  24  8.4  ND  24  0.4 
1  48  9.6  ND  454  2.9 
1  72  11.8  ND  563  3.3 
2  0  0  ND 
2  48  6.2  ND  50  0.6 
2  72  6.8  ND  67  0.7 
3  0  38  ND 
3  60  17.0  ND  1,327  15.6 
4  60  13.0  ND  849  7.4 
* Infected cells/10  e PBL, assayed in PS cells  (i).  Infectious  center measured 
after  90 min incubation of  D2V and aD4 with PBL (time = 0 hours). 
5 ND, not done. 
TABLE  IV 
Replication  of D2V in Nonimmune Rhesus Tissue Leukocyte Cultures  in the Presence 
(aD4) and Absence  (FCS) of aD4 
Mean PFU, days 2-5,  ×  1,000/10  e mononuclear leukocytes 
Source of  leukocytes 
Monkey  Bone marrow  Spleen  Thymus  Lymph node 
aD4  FCS  aD4  FCS  aD4  FCS  aD4  FCS 
Rh 113  2.1  -+  0.5*  0.04  0.8  0.1  ND  ND  0.2  0.1 
Rh A  <0.02  <0.02  <0.02  <0.02  0.3  0.04  0.4  0.1 
Rh B  0.1  0.1  0.1  0.03  0.2  0.04  0.1  0.1 
Rh C  71.5  -+  6.05  0.2  <0.02  <0.02  <0.02  <0.02  <0.02  <0.02 
Rh D  3.3  -+  0.5  <0.02  <0.02  <0.02  <0.02  <0.02  <0.02  <0.02 
Virus antibody added to freshly  prepared leukocyte cultures. 
* SE of  mean shown for values >1.0. 
5 Day 5 culture contained 189,000  PFU/ml. 
only was added to  cells.  After  incubation at 37°C,  virus content was assayed  on 
days 1-6.  Table  IV  shows  mean plaque  counts  from  days  2  to  5  of  cultures.  When 
D2V-aD4 was added on day 0, virus  replicated  in three of  five  bone marrow 
cultures. In two animals (Rh 113,  Rh D) virus  titers  approximated those of 
peripheral  blood.  The third  culture (Rh C), produced the highest in vitro  D2V 
titer  of  the experimental series.  Low level  replication  was observed in some 
spleen, thymus, and lymph node suspensions. When D2V plus aD4 was added to 
tissue leukocytes after 48-96 h in vitro incubation, virus consistently replicated 
in bone marrow cells but not in leukocytes from other lymphatic tissues (Table 
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TABLE  V 
Replication of  D2 V in Nonimmune Rhesus Tissue Leukocyte Cultures in the Presence 
and Absence of aD4 
Mean PFU days 3-5  ×  1,000/10  s mononuclear leukocytes 
Day in-  Source of lenkocytes 
Monkey  fected  Bone marrow  Spleen  Thymus  Lymph node 
aD4  FCS  aD4  FCS  aD4  FCS  aD4  FCS 
Rh 113  2  1.3  -+ 0.3*  0.3  0.2  0.09  ND  ND  0.17  0.1 
Rh A  2  0.9 ±  0.5  0.1  0.04  0.04  0.05  0.03  0.07  0.04 
Rh B  2  1.3 ± 0.6  0.2  0.06  0.06  0.2  0.05  0.6  <0.02 
Rh C  4  67.1 ± 6.0  1.3 ± 0.7  0.15  0.01  0.1  0.07  0.06  <0.01 
Rh D  4  3.7 ± 0.8  0.5  0.1  0.08  ND  ND  <0.01  <0.01 
Virus antibody added after leukocytes held for 48 or 96 h at 37°C. 
* SE of mean shown for values >1.0. 
TABLE  VI 
Mononuclear Phagocytes in Rhesus Tissue Leukocyte Cultures 
Mononuclear phagocytes × i0  ~ 
Monkey  Bone marrow  Spleen  Thymus  Lymph node 
Day  .......  0  3  0  3  0  3  0  3 
Rh 113  1.3  1.8  0.5  0.7  ND  ND  0.05  <0.01 
Rh A  ND  1.0  ND  0.8  ND  0.01  ND  0.02 
Rh B  ND  2.4  ND  0.4  ND  0.02  ND  0.02 
Rh C  1.3  1.7  0.3  0.4  0.08  0.08  0.07  0.06 
Rh D  1.0  1.4  0.3  0.4  ND  ND  <0,01  <0.01 
On day 0 all  cultures  contained 1 x l0  s  mononuclear leukocytes. 
Virus replication occurred in leukocyte populations with the highest propor- 
tion  of mononuclear phagocytes  (Table  VI).  Silica  treatment  reduced D2V 
replication in tissue leukocytes, although not as completely as in peripheral 
blood cultures  (Table VII). This  may have been related to the use in these 
experiments  of stored  silica  suspensions.  When  bone  marrow,  spleen,  and 
thymus leukocyte suspensions  incubated with latex were stained with anti- 
dengue FITC, fluorescence-positive cells were observed to have phagocytosed 
latex and to have mononuclear phagocyte morphology. 
Discussion 
In preliminary studies  using leukocytes  from dengue-immune monkey do- 
nors, it had been noted that virus replication was associated with weakly rather 
than strongly glass-adherent PBL (6). In addition, virus replicated in mitogen- 
stimulated non-immune PBL (7).  From these data we surmised that lympho- 
cytes,  possibly  B  cells,  might  be  the  site  of dengue  virus  synthesis.  This 
hypothesis  was reinforced  when we and others  observed  D2V  replication  in 
human B  lymphoblastoid cells  (8,  9).  The present results do not support this 
hypothesis. When D2V and appropriate concentrations of dengue antibodies are 
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TAs~.~. VII 
Effect of lO0 p.g/ml Particulate Silica on the Replication of D2V in Cultured Tissue 
Leukocytes 
Mean PFU days 2-5  ×  1,000/10 e mononuclear leukocytes 
Day 
Monkey  in-  Bone Marrow  Spleen  Thymus  Lymph node 
fected 
Control  Silica  Control  Silica  Control  Silica  Control  Silica 
Rh 113  0  2.1  +_ 0.5*  0.4  0.8  0.06  ND  ND  0.2  <0.02 
Rh C  0  71.5 +  6.0  3.9 -+ 0.9  <0.02  ND  <0.02  ND  <0.02  ND 
Rh D  0  4.1  _  0.7  1.0 +_ 0.3  <0.02  ND  <0.02  ND  <0.02  ND 
Rh 113  2  1.3  ±  0.3  0.2  ND  ND  ND  ND  ND  ND 
Rh A  2  0.9  ±  0.5  0.08  ND  ND  ND  ND  ND  ND 
Rh B  2  1.3  ±  0.6  0.2  ND  ND  ND  ND  ND  ND 
Rh C  4  67.1  ±  6.0  2.7  ±  0.7  0.15  0.2  0.1  0.02  0.06  <0.02 
Rh D  4  3.7  _+  0.8  0.7  0.08  <0.02  ND  ND  <0.01  ND 
* SE of mean for values >1.0. 
virus enters and replicates exclusively in mononuclear phagocytes. Evidence 
supporting this conclusion is that D2V replication is associated with a surface- 
adherent, radiation-resistant cell and that D2V replication does not occur when 
PBL  cultures were selectively depleted of mononuclear phagocytes by silica 
treatment or by application to a  100% autologous serum nylon wool column. 
When FITC-stained dengue-infected  leukocytes were visualized under UV light 
all fluorescence-positive  cells had abundant cytoplasm, resembled mononuclear 
phagocytes in size and cell membrane character, and a large majority had been 
actively phagocytic. 
Theofilopoulos and co-workers have recently presented suggestive evidence of 
low level dengue infection in unfractionated human PBL and in monolayers of 
plastic-adherent human leukocytes, all cultured for 3 days before addition of 
D2V (9). These workers also described D2V replication in unfractionated PBL 
stimulated for 3 days by phytohemagglutinin  or pokeweed mitogen (PWM) then 
infected and in PWM-stimulated PBL which had been depleted ofT lymphocytes 
and of colloidal iron-adsorbant cells. Many of these data are difficult to inter- 
pret. The number of replicate experiments, the number and dengue-immune 
status of PBL donors, and the confidence limits of measurements of virus concen- 
trations are not given. In only one experiment  does peak virus production exceed 
the 24-h postinoculation titer by more than fourfold, a change in virus concen- 
tration which is less than the experimental error of the dengue plaque assay. 
Although the authors argue that dengue virus replication was demonstrated in 
mitogen-treated B  lymphocytes, no  evidence was  provided to  show  how  or 
whether lymphocyte-like  monocyte precursors were excluded by the separation 
techniques employed. Monocytes demonstrate EAC rosetting and can possess 
membrane immunoglobulin, criteria which were used to demonstrate the purity 
of putative B lymphocytes. 
We have performed a small number of experiments in which PBL were held 
for 3 days in culture before adding D2V. As reported (1), PBL from nonimmune 
human donors did not become spontaneously permissive to D2V through 96 h. It 
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within a few hours of collection supported virus replication beginning on day 4 
or 5 of incubation (1). Except for the difference in time of addition of virus, this 
delayed growth of dengue virus resembles viral growth described by Theofilo- 
poulos et al.  (9). The late replication of D2V in nonimmune monkey PBL was 
observed sporadically. Attempts to study the phenomenon  were impeded by our 
inability to  attain  reproducibility. We have not determined which cell type 
supports delayed dengue virus replication in monkey PBL. This phenomenon is 
seemingly at variance with observations in human PBL which showed a  de- 
creasing permissiveness of mononuclear phagocytes to  infection by  immune 
complexes with time in culture. 
D2V replicates in PBL which demonstrate weak surface adherence. As shown 
in Fig.  1, when preinfected PBL were allowed to attach to a  plastic surface, 
virus-containing cells were found among beth adherent and nonadherent popu- 
lations. This same experiment, with minor modifications, has been repeated 
numerous times using monkey and human cells with  similar results.  This 
suggests the existence of a  dengue-permissive monocyte subpopulation. This 
hypothesis is supported by additional observations: (a) When held for 2 or more 
days in culture before adding immune complexes, human and monkey PBL 
become relatively insusceptible to antibody-mediated dengue infection. During 
the same period the absolute number of mature monocytes increased (Table I). 
(b) By contrast, even after 4 days in culture, simian bone marrow leukocytes 
supported antibody-mediated dengue infection at undiminished  levels compared 
with day 0. (c) As evidenced by the number of fluorescence-positive cells, a very 
small proportion of mononuclear phagocytes are infected by D2V, usually less 
than I%. 
Horwitz  and  Steagall  have  described as  a  macrophage precursor  a  large 
lymphocyte found in the blood of patients with infections (10). We have noted 
Consistently in our experiments an absolute increase in cultured human mono- 
nuclear phagocytes over a 48-96 h period which is accompanied by an absolute 
decrease in lymphocytes. Monocytes originate in the bone marrow from precur- 
sors (11). Monocytes and small numbers of promonocytes are released into the 
blood (12). It is likely that any increase in the number of blood monocytes with 
time in  culture  must result  from a  maturational  change  since little  or  no 
division of these cells has been observed (12). By contrast, cultured bone marrow 
colonies continuously produce monocytes and  monocyte precursors  (13,  14). 
Thus, the gradual loss of dengue-permissive cells in cultured PBL, the steady 
state of permissiveness in bone marrow leukocyte cultures over the same time 
period, and the very small number of dengue-infected cells are consistent with 
the hypothesis that dengue virus replicates in an immature monocyte. Simi- 
larly, the survival of D2V after phagocytosis suggests as a possible explanation 
the  infection of a  cell  possessing the property of immune phagocytosis but 
lacking an efficient intracellular-killing mechanism. 
In the preceding paper we suggested as a test of the enhancement hypothesis, 
the measurement of the size of the dengue-permissive leukocyte population in 
groups of human beings who respond to dengue infection with mild or severe 
disease  (1). Data presented here suggest that the most accurate method for 
enumerating dengue-infected leukocytes is  the FA technique. The  standard 
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underestimated the number of infected cells.  We  have no  insight into  this 
phenomenon, but it may be speculated that the methods used to separate PBL 
may render them temporarily insusceptible to dengue infection. The repeated 
centrifugations required  for the  infectious center assay for  example might 
deplete permissive cells  or  in  some way inhibit  virus  replication.  Such  an 
hypothesis would be consistent with the observation that virus replicates to a 
higher titer if virus and antibody are added to PBL after 24 h  of cultivation 
rather than immediately  after the separation procedure (1). Alternatively, anti- 
D2 may inactivate leukocytes with exteriorized dengue antigen. Finally, in the 
environment of the assay system infected PBL may not survive. We have shown 
that D2V-aD4-infected mononuclear leukocytes incubated in L-15 medium will 
not sustain viral replication (1). Further studies are required to clarify problems 
in the assay of isolated dengue-infected leukocytes. 
Employing the methodology  described, antibody-mediated  dengue infection of 
normal human and simian mononuclear phagocytes is highly reproducible. The 
method allows use of relatively abundant dengue nonimmune persons as PBL 
donors  and  allows  antibody,  virus,  and  cell  experimental controls.  Further 
studies on this phenomenon may contribute toward an understanding of patho- 
genetic mechanisms in dengue. 
Summary 
Studies  were  made  on  the  identity  of human  and  monkey mononuclear 
leukocytes permissive to antibody-enhanced dengue 2 virus (D2V) infection. In 
cultures of peripheral  blood  leukocytes (PBL)  inoculated immediately after 
separation, it was concluded that only mononuclear phagocytes support dengue 
infection.  This  is  based  upon  observations  that  D2V-permissive  cells  were 
resistant  to  1,200 rads,  were both  plastic  adherent and  nonadherent,  were 
removed when passed through nylon wool columns in 10% fetal bovine serum 
or 100% autologous serum, and were destroyed by incubation with 100  /~g/ml 
particulate silica. On direct immunofluorescence staining, perinuclear dengue 
antigen was visualized at 24 h, becoming maximal at 60 h. Antigen-containing 
cells had ample cytoplasm, ruffled cytoplasmic membrane, and 73% were ac- 
tively phagocytic. As further evidence of the infection of mononuclear phago- 
cytes, antibody-enhanced D2V replication was observed in bone marrow cul- 
tures  from five  of five rhesus  monkeys, but  not  in  cell cultures of spleen, 
thymus, or lymph nodes prepared from the same animals. It is hypothesized that 
dengue virus complexed with non-neutralizing antibody is internalized by im- 
mune phagocytosis in a mononuclear phagocyte with a defective virus-destroy- 
ing mechanism. Dengue permissiveness may depend upon cellular immaturity 
since bone marrow leukocytes could be infected even when held for 4 days before 
infection while PBL held for this time decreased in permissiveness. In vitro 
antibody-dependent infection of mononuclear phagocytes should prove useful as 
a model for study of immunopathologic mechanisms in human dengue. 
We are grateful to Mr. Colin Green, Wing Commander Tony Nicholson, and Surgeon Captain N. 
J. Blacklock for providing monkey tissues for study. 
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